Is there a role for PET-CT-directed therapy in DLBCL?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Judith Trotman, Concord Repatriation General Hospital, Sydney, AU. We asked, Is there a ro...
17 Joulu 202015min
Can we eliminate auto-SCT for patients with MCL?
During the European School of Haematology (ESH)'s 2nd How to Diagnose & Treat Lymphoma conference, the Lymphoma Hub spoke to Marco Ladetto, SS Antonio e Biagio e Cesare Arrigo, Alessandria, IT, who di...
11 Marras 20205min
Can we avoid chemotherapy entirely in follicular lymphoma?
During the European School of Haematology (ESH)'s 2nd How to Diagnose & Treat Lymphoma conference, the Lymphoma Hub spoke to Nathan Fowler, MD Anderson Cancer Center, Houston, US, who discussed the no...
9 Marras 202011min
An update in CLL from EHA 2020
During the 25th European Hematology Association (EHA) Annual Congress, the Lymphoma Hub spoke to Susan O'Brien, University of California Irvine, Orange, US, who discussed the latest updates on chronic...
14 Heinä 20206min
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease
During the American Association of Cancer Research (AACR) Virtual Annual Meeting I, the Lymphoma Hub was pleased to speak to Christine Spencer, Parker Institute for Cancer Immunotherapy, San-Francisco...
17 Kesä 202024min
